Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
clinical trials
fda
life sciences
national blog main
abaloparatide
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
amgen
aminolevulinic acid
bigdata
biotech
boston
boston blog main
boston top stories
datascience
deeplearning
drugs
europe blog main
europe top stories
european commission
givosiran
iot
machinelearning
ml
national
nlp
onpattro
osteoporosis
patisiran
paul matteis
radius health
rna interference
robots
romosozumab
san francisco blog main
san francisco top stories
stifel financial
teriparatide
ucb
What
medicine
3
×
nod
3
×
approval
drug
ago
alnylam
amgen
amgen’s
article
carries
demo
developed
europe
european
fda
heart
indicated
interference
learning
machine
marketing
osteoporosis
personalized
pharmaceuticals
quick
raise
read
risk
rna
rnai
second
seek
speedy
warning
weeks
wins
won’t
year
Language
unset
Current search:
nod
×
medicine
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@IainLJBrown
6 years ago
'Article of the Year' nod to demo of machine learning for personalized medicine Read more here: https://ift.tt/2HcK4oJ #MachineLearning #ML #DataScience #DeepLearning #NLP #Robots #AI #IoT #BigData